Advisor Group Holdings, Inc. Palisade Bio, Inc. Transaction History

Advisor Group Holdings, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.41 - $1.04 $1,232 - $3,127	-3,007 Reduced 73.34%	1,093 $0
Q1 2022 May 04, 2022	BUY	$0.81 - $1.51 $3,250 - $6,059	4,013 Added 4612.64%	4,100 $4,000
Q3 2021 Nov 05, 2021	BUY	$2.35 - $3.93 $2 - $3	1 Added 1.16%	87 $0
Q2 2021 Aug 02, 2021	BUY	$3.49 - $11.34 $300 - $975	86 New	86 $0

Ticker PALI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,240,200
Market Cap $323M
Description
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzym...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.